FindTrial
Sign In

To assess predisposing factors in patients of mucormycosis following COVID infection at a tertiary hospital in North India

Epidemiological analysis in patients of Mucormycosis at a tertiary care center in North India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037466
Enrollment
70
Registered
2021-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B463- Cutaneous mucormycosis Health Condition 3: B464- Disseminated mucormycosis Health Condition 4: B465- Mucormycosis, unspecified Health Condition 5: B461- Rhinocerebral mucormycosis

Interventions

None listed

Sponsors

NITIKA BERI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Mucormycosis admitted at the tertiary care center

Exclusion criteria

Exclusion criteria: Patients without Mucormycosis admitted at the hospital and patients who do not give consent to be a part of the study.

Design outcomes

Primary

MeasureTime frame
To assess predisposing factors for MucormycosisTimepoint: At baseline—

Secondary

MeasureTime frame
Association of severity of disease with predisposing factors.Timepoint: At baseline—

Countries

India

Contacts

Public ContactNITIKA BERI

University College of Medical Sciences and GTB Hospital

berinitika@gmail.com9871130760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026